Abo Bibliothek: Guest
Journal of Environmental Pathology, Toxicology and Oncology

Erscheint 4 Ausgaben pro Jahr

ISSN Druckformat: 0731-8898

ISSN Online: 2162-6537

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.4 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.8 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.5 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00049 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.59 SJR: 0.429 SNIP: 0.507 CiteScore™:: 3.9 H-Index: 49

Indexed in

Increased Expression of COX-2 in the Development of Human Lung Cancers

Volumen 21, Ausgabe 2, 2002, 5 pages
DOI: 10.1615/JEnvironPatholToxicolOncol.v21.i2.110
Get accessGet access

ABSTRAKT

It is well accepted that an increase in the expression of cyclooxygenase-2 (COX-2), a key inducible enzyme involved in the production of prostaglandins and other eicosanoids, may play a significant role in carcinogenesis in addition to its well-known role in inflammatory reactions. Whereas previous studies were largely confined to colorectal tumorigenesis, we have shown that a significantly increased expression of COX-2 may also play a role in the development of lung cancer. COX-2 expression was found to be frequently elevated in lung cancer, especially in adenocarcinoma, and the proportion of lung cancer cells with marked COX-2 expression was much higher in lymph node metastases than in the corresponding primary tumors. It was also shown that early stage adenocarcinoma patients with increased COX-2 expression who were surgically treated had a shorter survival. Our studies, which used high- and low-metastatic human lung cancer cell sublines established in our laboratory, revealed an association between metastatic capabilities and COX-2 expression levels: COX-2-specific inhibitors could inhibit in vitro the invasion of the highly metastatic NCI-H460-LNM35 clone through Matrigel-containing basement membrane components as well as the spontaneous in vivo metastasis in SCID mice. Taken together, these findings suggest that an increase in COX-2 expression may be associated with the development of lung cancer and possibly with the acquisition of an invasive and metastatic phenotype.

REFERENZIERT VON
  1. Ballaz Santiago, Mulshine James L., The Potential Contributions of Chronic Inflammation to Lung Carcinogenesis, Clinical Lung Cancer, 5, 1, 2003. Crossref

  2. Lopes Luciane C., de Carvalho João Ernesto, Kakimore Marise, Vendramini-Costa Débora B., Medeiros Maria A., Spindola Humberto M., Ávila-Román Javier, Lourenço Ana M., Motilva Virginia, Pharmacological characterization of Solanum cernuum Vell.: 31-norcycloartanones with analgesic and anti-inflammatory properties, Inflammopharmacology, 2013. Crossref

  3. Kabadere Selda, Kus Gokhan, Uyar Ruhi, Oztopcu-Vatan Pinar, Licofelone abolishes survival of carcinogenic fibroblasts by inducing apoptosis, Drug and Chemical Toxicology, 37, 1, 2014. Crossref

  4. Lev-Ari Shahar, Starr Alex, Katzburg Sara, Berkovich Liron, Rimmon Adam, Ben-Yosef Rami, Vexler Akiva, Ron Ilan, Earon Gideon, Curcumin induces apoptosis and inhibits growth of orthotopic human non-small cell lung cancer xenografts, The Journal of Nutritional Biochemistry, 25, 8, 2014. Crossref

  5. Wang Man-Tzu, Honn Kenneth V., Nie Daotai, Cyclooxygenases, prostanoids, and tumor progression, Cancer and Metastasis Reviews, 26, 3-4, 2007. Crossref

  6. Ghosh Nilanjan, Chaki Rituparna, Mandal Vivekananda, Mandal Subhash C., COX-2 as a target for cancer chemotherapy, Pharmacological Reports, 62, 2, 2010. Crossref

  7. Menter David G, Cyclooxygenase 2 selective inhibitors in cancer treatment and prevention, Expert Opinion on Investigational Drugs, 11, 12, 2002. Crossref

  8. Cárdeno Ana, Aparicio-Soto Marina, Montserrat-de la Paz Sergio, Bermudez Beatriz, Muriana Francisco J.G., Alarcón-de-la-Lastra Catalina, Squalene targets pro- and anti-inflammatory mediators and pathways to modulate over-activation of neutrophils, monocytes and macrophages, Journal of Functional Foods, 14, 2015. Crossref

  9. Dai Yinmei, Zhang Xiangdong, Peng Yunhua, Wang Ziren, The expression of cyclooxygenase-2, VEGF and PGs in CIN and cervical carcinoma, Gynecologic Oncology, 97, 1, 2005. Crossref

  10. Vegeler Reid C., Yip-Schneider Michele T., Ralstin Matthew, Wu Huangbing, Crooks Peter A., Neelakantan Sundar, Nakshatri Harikrishna, Sweeney Christopher J., Schmidt C. Max, Effect of Celecoxib and Novel Agent LC-1 in a Hamster Model of Lung Cancer, Journal of Surgical Research, 143, 1, 2007. Crossref

  11. Méric Jean-Baptiste, Rottey Sylvie, Olaussen Ken, Soria Jean-Charles, Khayat David, Rixe Olivier, Spano Jean-Philippe, Cyclooxygenase-2 as a target for anticancer drug development, Critical Reviews in Oncology/Hematology, 59, 1, 2006. Crossref

  12. Zhao Shipeng, Cai Jianhui, Bian Honglei, Gui Lin, Zhao Fa, Synergistic Inhibition Effect of Tumor Growth by Using Celecoxib in Combination With Oxaliplatin, Cancer Investigation, 27, 6, 2009. Crossref

  13. de Groot D.J.A., de Vries E.G.E., Groen H.J.M., de Jong S., Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: From lab to clinic, Critical Reviews in Oncology/Hematology, 61, 1, 2007. Crossref

  14. Kim Joohwee, Shim Minsub, COX-2 inhibitor NS-398 suppresses doxorubicin-induced p53 accumulation through inhibition of ROS-mediated Jnk activation, Molecular Carcinogenesis, 55, 12, 2016. Crossref

  15. Moysich Kirsten B, Menezes Ravi J, Ronsani Adrienne, Swede Helen, Reid Mary E, Cummings K Michael, Falkner Karen L, Loewen Gregory M, Bepler Gerold, Regular aspirin use and lung cancer risk, BMC Cancer, 2, 1, 2002. Crossref

  16. Huang Dong-Sheng, Specific COX-2 inhibitor NS398 induces apoptosis in human liver cancer cell line HepG2 through BCL-2, World Journal of Gastroenterology, 11, 2, 2005. Crossref

  17. Wang Xiao-Hu, Effects of adenovirus-mediated human cyclooxygenase-2 antisense RNA on the growth of hepatocellular carcinoma, World Journal of Gastroenterology, 11, 39, 2005. Crossref

  18. Martey Christine A., Pollock Stephen J., Turner Chantal K., O'Reilly Katherine M. A., Baglole Carolyn J., Phipps Richard P., Sime Patricia J., Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer, American Journal of Physiology-Lung Cellular and Molecular Physiology, 287, 5, 2004. Crossref

  19. Stratton M. Suzanne, Stratton Steven P., Dionne Sara O., Thompson Patricia, Jongewaard Ian N., Hakim Iman, Dilley Tarrah, Garland Linda, Ranger-Moore James, Alberts David S., Ahmann Frederick M., Treatment of Carcinogenesis, in Principles of Molecular Oncology, 2004. Crossref

  20. Korga Agnieszka, Ostrowska Marta, Iwan Magdalena, Skierucha Małgorzata, Józefczyk Aleksandra, Pawłowski Piotr, Dudka Jarosław, Maciejewski Ryszard, Sitarz Robert, Ethanol extracts of Allium sp. regulate cyclooxygenase-2 and E-cadherin expression in gastric cancer MKN74 cell line and enhance doxorubicin toxicity, Food & Nutrition Research, 63, 2019. Crossref

  21. Kawamoto Hironori, Hara Hiromichi, Araya Jun, Ichikawa Akihiro, Fujita Yu, Utsumi Hirofumi, Hashimoto Mitsuo, Wakui Hiroshi, Minagawa Shunsuke, Numata Takanori, Arihiro Seiji, Matsuura Tomokazu, Fujiwara Mutsunori, Ito Satoru, Kuwano Kazuyoshi, Prostaglandin E-Major Urinary Metabolite (PGE-MUM) as a Tumor Marker for Lung Adenocarcinoma, Cancers, 11, 6, 2019. Crossref

  22. Yu Le, Chen Minghui, Li Zhijie, Wen Jing, Fu Jianhua, Guo Dan, Jiang Yong, Wu Shuguang, Cho Chi-Hin, Liu Shuwen, Celecoxib Antagonizes the Cytotoxicity of Cisplatin in Human Esophageal Squamous Cell Carcinoma Cells by Reducing Intracellular Cisplatin Accumulation, Molecular Pharmacology, 79, 3, 2011. Crossref

  23. Lee Juliette L, Mukhtar Hasan, Bickers David R, Kopelovich Levy, Athar Mohammad, Cyclooxygenases in the skin: pharmacological and toxicological implications, Toxicology and Applied Pharmacology, 192, 3, 2003. Crossref

  24. Ibrahim Nurul ‘Izzah, Naina Mohamed Isa, Interdependence of Anti-Inflammatory and Antioxidant Properties of Squalene–Implication for Cardiovascular Health, Life, 11, 2, 2021. Crossref

  25. Tammemagi C. Martin, Freedman Matthew T., Church Timothy R., Oken Martin M., Hocking William G., Kvale Paul A., Hu Ping, Riley Thomas L., Ragard Lawrence R., Prorok Philip C., Berg Christine D., Factors Associated with Human Small Aggressive Non–Small Cell Lung Cancer, Cancer Epidemiology, Biomarkers & Prevention, 16, 10, 2007. Crossref

  26. Nagaraj Gopinath, Dhanusu Suresh, Nachiappan Dhatchana Moorthy, Vellaichamy Elangovan, C-Type Natriuretic Peptide (CNP) Induces Cell Death and Sensitizes the Effect of Cisplatin in Human Non-small Cell Lung Cancer Cells (A549), International Journal of Peptide Research and Therapeutics, 28, 4, 2022. Crossref

Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen Preise und Aborichtlinien Begell House Kontakt Language English 中文 Русский Português German French Spain